spacer
home > ict > summer 2008 > true interoperability
PUBLICATIONS
International Clinical Trials

True Interoperability

Over recent years there has been a marked proliferation of electronic technologies to manage and conduct clinical trials in a more efficient and/or automated manner. It is now commonplace for a biopharmaceutical organisation to make use of a multitude of electronic solutions to help simplify the clinical trials process.

Typical systems in the mix include clinical trials management system (CTMS), interactive voice response (IVR), electronic data capture (EDC), electronic patient reported outcomes (ePROs), drug supply management system (DSMS) and many more. Individually, they provide specific functionalities for handling particular aspects of the clinical trial process and their adoption across the industry shows no sign of slowing down. As the usage of individual technologies continues to soar, there is an increasing need to enable these separate systems to interact with each other in an efficient and synergistic manner.

Contributing to the ever-growing need for clinical trial technologies is the simple fact that managing clinical trials is a complex affair. In administrative terms alone, managing clinical trials involves numerous and interdependent activities that require coordination and tracking, such as obtaining ethics approvals for individual sites and making the correct payments to investigators in a timely manner. Against that backdrop, CTMS tools are increasingly becoming the solution of choice for streamlining the complex chain of management and administrative activities.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
David Stein is ClinPhone’s VP of Product Management and plays a pivotal role in managing ClinPhone’s products and services, as well as developing new technology solutions to improve the clinical trials process. He joined ClinPhone in November of 2002. Prior to joining the company, David worked in strategic business development and marketing at PhaseForward. He also founded, and later sold, an electronic patient reported outcomes company. Earlier in his career, he established the data management department for a mid-sized CRO and directed the group for three years. David was also an independent consultant in the field of pharmaceutical technologies for eight years and co-developed several custom software packages.

Dr Bill Byrom joined ClinPhone in July 2000 where he is the VP of Product Strategy and Marketing. He holds responsibility for providing strategic direction to ClinPhone’s suite of products including developing new areas of technology application within clinical trials and healthcare. Bill joined the pharmaceutical industry in 1991 after completing a PhD in disease control simulation at Strathclyde University, and has worked in a number of roles within statistics, clinical development and international marketing. Bill is the author of over 50 articles and chapters in professional journals and publications. Email: info@clinphone.com

spacer
David Stein
spacer
spacer
spacer
Dr Bill Byrom
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Our responsibility: employee health and taking care of patients needs

Düsseldorf, March 24, 2020. We as Gerresheimer face up to the special situation in view of the corona virus which is spreading worldwide. We are aware of our role as a key supplier of medicines and supplies for everyday life.
More info >>

White Papers

Advances in Aseptic Blow-Fill-Seal Processing of Pharmaceutical Liquids Improve Product Integrity and Patient Safety

Weiler Engineering, Inc

The latest improvements in aseptic blow-fill-seal technology are providing more streamlined automation of critical B/F/S processing areas, while limiting human intervention and effectively reducing airborne microbial bioburden and particulate levels, and enhancing sterility assurance and patient safety.
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement